This research review examines TB4-Fragment’s potential for treating kidney disease. The peptide shows promise in protecting kidney cells, reducing inflammation, and preventing harmful scarring in both acute and chronic kidney injuries. While the results are encouraging across multiple studies, researchers note that peptide stability and delivery remain key challenges for practical clinical use.
For your business
TB4-Fragment demonstrates significant kidney protective effects by reducing inflammation and preventing tissue scarring, which could benefit patients with kidney dysfunction or those at risk for kidney disease.